TEM Quote, Financials, Valuation and Earnings

GoodRx Holdings, Inc. has a net margin of -23.93% compared to Tempus AI, Inc.'s net margin of 0.57%. Tempus AI, Inc.'s return on equity of -81.31% beat GoodRx Holdings, Inc.'s return on equity of 4.78%.

Tempus AI, Inc. has a consensus price target of $88.92, signalling upside risk potential of 37.39%. On the other hand GoodRx Holdings, Inc. has an analysts' consensus of $4.88 which suggests that it could grow by 77.58%. Given that GoodRx Holdings, Inc. has higher upside potential than Tempus AI, Inc., analysts believe GoodRx Holdings, Inc. is more attractive than Tempus AI, Inc..

Tempus AI, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison GoodRx Holdings, Inc. has a beta of 1.470, suggesting its more volatile than the S&P 500 by 47.004%.

Tempus AI, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. GoodRx Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tempus AI, Inc. pays 0.8% of its earnings as a dividend. GoodRx Holdings, Inc. pays out -- of its earnings as a dividend. Tempus AI, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Tempus AI, Inc. quarterly revenues are $334.2M, which are larger than GoodRx Holdings, Inc. quarterly revenues of $196M. Tempus AI, Inc.'s net income of -$80M is lower than GoodRx Holdings, Inc.'s net income of $1.1M. Notably, Tempus AI, Inc.'s price-to-earnings ratio is -- while GoodRx Holdings, Inc.'s PE ratio is 32.01x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tempus AI, Inc. is 9.97x versus 1.26x for GoodRx Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

GE Healthcare Technologies, Inc. has a net margin of -23.93% compared to Tempus AI, Inc.'s net margin of 9.02%. Tempus AI, Inc.'s return on equity of -81.31% beat GE Healthcare Technologies, Inc.'s return on equity of 24.49%.

Tempus AI, Inc. has a consensus price target of $88.92, signalling upside risk potential of 37.39%. On the other hand GE Healthcare Technologies, Inc. has an analysts' consensus of $89.22 which suggests that it could grow by 7.09%. Given that Tempus AI, Inc. has higher upside potential than GE Healthcare Technologies, Inc., analysts believe Tempus AI, Inc. is more attractive than GE Healthcare Technologies, Inc..

Tempus AI, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison GE Healthcare Technologies, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Tempus AI, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. GE Healthcare Technologies, Inc. offers a yield of 0.17% to investors and pays a quarterly dividend of $0.04 per share. Tempus AI, Inc. pays 0.8% of its earnings as a dividend. GE Healthcare Technologies, Inc. pays out 2.88% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Tempus AI, Inc. quarterly revenues are $334.2M, which are smaller than GE Healthcare Technologies, Inc. quarterly revenues of $5.1B. Tempus AI, Inc.'s net income of -$80M is lower than GE Healthcare Technologies, Inc.'s net income of $464M. Notably, Tempus AI, Inc.'s price-to-earnings ratio is -- while GE Healthcare Technologies, Inc.'s PE ratio is 17.23x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tempus AI, Inc. is 9.97x versus 1.89x for GE Healthcare Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

National Research Corp. has a net margin of -23.93% compared to Tempus AI, Inc.'s net margin of 11.54%. Tempus AI, Inc.'s return on equity of -81.31% beat National Research Corp.'s return on equity of 61.55%.

Tempus AI, Inc. has a consensus price target of $88.92, signalling upside risk potential of 37.39%. On the other hand National Research Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Tempus AI, Inc. has higher upside potential than National Research Corp., analysts believe Tempus AI, Inc. is more attractive than National Research Corp..

Tempus AI, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison National Research Corp. has a beta of 0.447, suggesting its less volatile than the S&P 500 by 55.256%.

Tempus AI, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. National Research Corp. offers a yield of 2.53% to investors and pays a quarterly dividend of $0.12 per share. Tempus AI, Inc. pays 0.8% of its earnings as a dividend. National Research Corp. pays out 45.99% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Tempus AI, Inc. quarterly revenues are $334.2M, which are larger than National Research Corp. quarterly revenues of $34.6M. Tempus AI, Inc.'s net income of -$80M is lower than National Research Corp.'s net income of $4M. Notably, Tempus AI, Inc.'s price-to-earnings ratio is -- while National Research Corp.'s PE ratio is 26.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tempus AI, Inc. is 9.97x versus 3.11x for National Research Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Spok Holdings, Inc. has a net margin of -23.93% compared to Tempus AI, Inc.'s net margin of 9.46%. Tempus AI, Inc.'s return on equity of -81.31% beat Spok Holdings, Inc.'s return on equity of 10.88%.

Tempus AI, Inc. has a consensus price target of $88.92, signalling upside risk potential of 37.39%. On the other hand Spok Holdings, Inc. has an analysts' consensus of $20.00 which suggests that it could grow by 62.41%. Given that Spok Holdings, Inc. has higher upside potential than Tempus AI, Inc., analysts believe Spok Holdings, Inc. is more attractive than Tempus AI, Inc..

Tempus AI, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Spok Holdings, Inc. has a beta of 0.438, suggesting its less volatile than the S&P 500 by 56.19%.

Tempus AI, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings, Inc. offers a yield of 9.67% to investors and pays a quarterly dividend of $0.31 per share. Tempus AI, Inc. pays 0.8% of its earnings as a dividend. Spok Holdings, Inc. pays out 171.77% of its earnings as a dividend. Tempus AI, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Spok Holdings, Inc.'s is not.

Tempus AI, Inc. quarterly revenues are $334.2M, which are larger than Spok Holdings, Inc. quarterly revenues of $33.9M. Tempus AI, Inc.'s net income of -$80M is lower than Spok Holdings, Inc.'s net income of $3.2M. Notably, Tempus AI, Inc.'s price-to-earnings ratio is -- while Spok Holdings, Inc.'s PE ratio is 16.16x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tempus AI, Inc. is 9.97x versus 1.92x for Spok Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.